InvestorsHub Logo
Followers 4
Posts 1330
Boards Moderated 0
Alias Born 01/01/2007

Re: food4thought post# 39003

Wednesday, 07/03/2013 1:15:17 PM

Wednesday, July 03, 2013 1:15:17 PM

Post# of 48302
My sense is that any compound, regardless of dosage, must be cleared by the FDA. I wouldn't be surprised if a grey-market emerged for nootropics. Whoever does that might run afoul of the FDA, but with multiple ampakines reaching the end of their patent life, but they would not have to worry about patent infringement.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News